Composition for improving liver health comprising gallocatechin gallate and isoquercitrin

Abstract

This specification discloses a method for improving liver health, including administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof. In an aspect, a composition including a complex component of Gallocatechin Gallate and Isoquercitrin effectively reduces oxidative stress and chronic inflammatory reaction that occurs during accumulation of lipids in liver tissue, thereby making it possible to enhance liver health and prevent, improve, or treat various liver diseases such as hepatitis, cirrhosis, and liver cancer.

What is claimed is: 
     
         1 . A method for improving liver health, comprising administering an effective amount of Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) to a subject in need thereof. 
     
     
         2 . The method according to  claim 1 , wherein the method is a method for preventing, improving, or treating a liver disease. 
     
     
         3 . The method according to  claim 2 , wherein the liver disease is at least one selected from the group consisting of hepatitis, fatty liver, cirrhosis, and liver cancer. 
     
     
         4 . The method according to  claim 2 , wherein the liver disease is an alcoholic liver disease. 
     
     
         5 . The method according to  claim 1 , wherein the Gallocatechin Gallate (GCG) and Isoquercitrin (IQC) are contained in a weight ratio of 9:1 to 1:9. 
     
     
         6 . The method according to  claim 1 , wherein the subject needs to reduce oxidative stress or inflammation in liver cells. 
     
     
         7 . The method according to  claim 6 , wherein the subject needs to reduce expression of one or more genes selected from the group consisting of IL-1b, IL-6, and iNOS. 
     
     
         8 . The method according to  claim 1 , wherein the subject needs to inhibit lipid accumulation in liver cells.